Evidence map›Paper›PMID 42685014›Full record

ArticlePloS one2026

Maternal outcomes at mid-altitudes in anemic pregnant women: Evidence from the WOMAN-2 trial.

Projestine Muganyizi, Amy Brenner, Aasia Kayani, Eni Balogun, Folasade Adenike Bello, Gibson Kagaruki, Haleema Shakur-Still, Ian Roberts, Kiran Javaid, Mwansa Ketty Lubeya and 4 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Projestine MuganyiziDepartment of Obstetrics and Gynaecology, University of Dar es Salaam, Mbeya College of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID https://orcid.org/0000-0002-8362-2408
Amy BrennerClinical Trials Unit, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Aasia KayaniGlobal Institute of Human Development, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
Eni BalogunClinical Trials Unit, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Folasade Adenike BelloDepartment of Obstetrics and Gynaecology, University of Ibadan College of Medicine Ibadan, Nigeria.ORCID https://orcid.org/0000-0002-3337-3335
Gibson KagarukiNational Institute for Medical Research-Tanzania (NIMR).
Haleema Shakur-StillClinical Trials Unit, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Ian RobertsClinical Trials Unit, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Kiran JavaidGlobal Institute of Human Development, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
Mwansa Ketty LubeyaDepartment of Obstetrics and Gynaecology, University of Zambia School of Medicine, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-8526-3410
Oladapo OlayemiDepartment of Obstetrics and Gynaecology, University of Ibadan College of Medicine Ibadan, Nigeria.
Rizwana ChaudhriGlobal Institute of Human Development, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
Raoul MansukhaniClinical Trials Unit, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Vwalika BellingtonDepartment of Obstetrics and Gynaecology, University of Zambia School of Medicine, Lusaka, Zambia.

Funding

Bill & Melinda Gates Foundation INV-007787Wellcome Trust
6 · The paper itself

Abstract

backgroundHigh residential altitude is associated with adverse pregnancy outcomes, yet most research has focused on elevations above 2500 meters. There is limited evidence on how altitude impacts maternal health below this threshold, where 99% of the global population resides. We investigated the effect of mid-altitudes on maternal outcomes among women with moderate to severe anemia who delivered in hospitals in four sub-Saharan and Asian countries.

methodsWe analysed data from the World Maternal Antifibrinolytic-2 (WOMAN-2) trial, which recruited anaemic women admitted for vaginal delivery across 42 hospital sites in Nigeria, Pakistan, Tanzania, and Zambia. We compared women in mid-altitudes (1,000-2,499 m) with those at low-altitudes (< 1,000 m) using postpartum blood loss as the primary outcome. The key secondary outcome was clinical postpartum haemorrhage (PPH). Additional secondary outcomes included prenatal maternal health indicators (gestational age at labor onset, hypertensive disorders of pregnancy, baseline hemoglobin, severe anemia, and mean arterial pressure [MAP]), as well as intrapartum intervention indicators (assisted delivery, use of medical pain control, and use of oxytocin in labor). We used STATA version 18 for data analysis. We used classical logistic and modified Poisson regressions with cluster-robust standard errors to estimate the odds and risk ratios (RR) for dichotomous outcomes and linear regression with cluster-robust variance to estimate the β coefficients for the continuous outcomes.

resultsOf 15,068 women, 4801 (31.9%) delivered at mid-altitude and 10,267 (68.1%) at low-altitudes. Delivery in mid-altitudes did not independently affect postpartum blood loss (β = 37.89 mL; 95% CI: -26.83-102.62), p = 0.243. Mid-altitude delivery compared to low-altitude was independently associated with a 22% lower risk of preterm delivery (aRR = 0.78; 95%CI: 0.73-0.83), p < 0.001, and a 26% lower risk of severe anaemia (aRR = 0.74; 95% CI: 0.68-0.82), p < 0.001. The use of medical pain control was 2.2 times higher (aRR = 2.20; 95% CI: 2.02-2.40), p < 0.001, and the Odds of assisted delivery were 46% more likely (aOR = 1.46; 95% CI: 1.20-1.78) at mid-altitudes compared to low-altitudes.

conclusionDelivery at mid-altitudes was not independently associated with postpartum blood loss, but generally exhibited more favorable prenatal maternal health indicators and more intrapartum interventions than those delivering at low-altitudes.

Indexed as

AltitudeAnemiaPostpartum HemorrhagePregnancy Complications, HematologicPregnancy OutcomeAdultFemaleHumansPregnancyYoung Adult

Identifiers

PMID42685014
PMCPMC13537555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.